Repurposing Alkylating Agents in Melanoma via ERCC8 Silencing: A Novel Therapeutic Strategy.

Cancers (Basel) · 2026 · PMC12939398 · PMID 41749901

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

The effect was highly significant in UACC-62, UACC-257, RPMI7951, and WM1366 cells ( p < 0.001), and significant in FB789 ( p < 0.01), confirming the specificity and efficacy of ASO-mediated silencing.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.